Zacks Investment Management Agenus Inc Transaction History

Zacks Investment Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $78,600 - $122,400	60,000 New	60,000 $96,000
Q4 2021 Feb 15, 2022	SELL	$2.92 - $5.74 $146,000 - $287,000	-50,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $249,000 - $331,500	50,000 New	50,000 $263,000
Q1 2018 May 14, 2018	SELL	$3.51 - $6.04 $115,471 - $198,703	-32,898 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.26 - $4.78 $674 - $989	207 Added 0.63%	32,898 $107,000
Q3 2017 Nov 14, 2017	BUY	$3.48 - $4.44 $113,764 - $145,148	32,691	32,691 $144,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.